FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000203039> ?p ?o ?g. }

• W2000203039 endingPage "526" @default.
• W2000203039 startingPage "518" @default.
• W2000203039 abstract "In this study, direct analysis in real time-mass spectrometry (DART-MS) was assessed for the analysis of various pharmaceutical formulations with intention to summarize possible applications for the routine pharmaceutical development. As DART is an ambient ionization technique, it allows direct analysis of pharmaceutical samples in solid or liquid form without complex sample preparation, which is often the most time-consuming part of the analytical method. This makes the technique suitable for many application fields, including pharmaceutical drug development. DART mass spectra of more than twenty selected tablets and other common pharmaceutical formulations, i.e. injection solutions, ointments and suppositories developed in the pharmaceutical industry during several recent years are presented. Moreover, as thin-layer chromatography (TLC) is still very popular for the monitoring of the reactions in the synthetic chemistry, several substances were analyzed directly from the TLC plates to demonstrate the simplicity of the technique. Pure substance solutions were spotted onto a TLC plate and then analyzed with DART without separation. This was the first DART-MS study of pharmaceutical dosage forms using DART–Orbitrap combination. The duration of sample analysis by the DART-MS technique lasted several seconds, allowing enough time to collect sufficient number of data points for compound identification. The experimental setup provided excellent mass accuracy and high resolution of the mass spectra which allowed unambiguous identification of the compounds of interest. Finally, DART mass spectrometry was also used for the monitoring of the selected impurity distribution in the atorvastatin tablets. These measurements demonstrated DART to be robust ionization technique, which provided easy-to-interpret mass spectra for the broad range of compounds. DART has high-throughput potential for various types of pharmaceutical analyses and therefore eliminates the time for sample cleanup and chromatographic separation." @default.
• W2000203039 created "2016-06-24" @default.
• W2000203039 creator A5002401814 @default.
• W2000203039 creator A5027716999 @default.
• W2000203039 creator A5029326112 @default.
• W2000203039 creator A5032630162 @default.
• W2000203039 creator A5037414877 @default.
• W2000203039 creator A5037800103 @default.
• W2000203039 creator A5073320580 @default.
• W2000203039 date "2014-12-01" @default.
• W2000203039 modified "2023-10-13" @default.
• W2000203039 title "Direct analysis in real time – High resolution mass spectrometry as a valuable tool for the pharmaceutical drug development" @default.
• W2000203039 cites W1971599950 @default.
• W2000203039 cites W1972505828 @default.
• W2000203039 cites W1973078838 @default.
• W2000203039 cites W1977610445 @default.
• W2000203039 cites W1988465709 @default.
• W2000203039 cites W1992985052 @default.
• W2000203039 cites W1996441617 @default.
• W2000203039 cites W2002973726 @default.
• W2000203039 cites W2013717323 @default.
• W2000203039 cites W2023527752 @default.
• W2000203039 cites W2024647894 @default.
• W2000203039 cites W2025228136 @default.
• W2000203039 cites W2025430266 @default.
• W2000203039 cites W2036443427 @default.
• W2000203039 cites W2039181272 @default.
• W2000203039 cites W2043042307 @default.
• W2000203039 cites W2052923805 @default.
• W2000203039 cites W2065431130 @default.
• W2000203039 cites W2068737772 @default.
• W2000203039 cites W2083323586 @default.
• W2000203039 cites W2086893332 @default.
• W2000203039 cites W2087856148 @default.
• W2000203039 cites W2105276471 @default.
• W2000203039 cites W2155892228 @default.
• W2000203039 cites W2156955341 @default.
• W2000203039 cites W4362231430 @default.
• W2000203039 cites W2644804608 @default.
• W2000203039 doi "https://doi.org/10.1016/j.talanta.2014.07.007" @default.
• W2000203039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25159441" @default.
• W2000203039 hasPublicationYear "2014" @default.
• W2000203039 type Work @default.
• W2000203039 sameAs 2000203039 @default.
• W2000203039 citedByCount "23" @default.
• W2000203039 countsByYear W20002030392015 @default.
• W2000203039 countsByYear W20002030392016 @default.
• W2000203039 countsByYear W20002030392017 @default.
• W2000203039 countsByYear W20002030392018 @default.
• W2000203039 countsByYear W20002030392019 @default.
• W2000203039 countsByYear W20002030392021 @default.
• W2000203039 countsByYear W20002030392022 @default.
• W2000203039 countsByYear W20002030392023 @default.
• W2000203039 crossrefType "journal-article" @default.
• W2000203039 hasAuthorship W2000203039A5002401814 @default.
• W2000203039 hasAuthorship W2000203039A5027716999 @default.
• W2000203039 hasAuthorship W2000203039A5029326112 @default.
• W2000203039 hasAuthorship W2000203039A5032630162 @default.
• W2000203039 hasAuthorship W2000203039A5037414877 @default.
• W2000203039 hasAuthorship W2000203039A5037800103 @default.
• W2000203039 hasAuthorship W2000203039A5073320580 @default.
• W2000203039 hasConcept C106186310 @default.
• W2000203039 hasConcept C113196181 @default.
• W2000203039 hasConcept C115139119 @default.
• W2000203039 hasConcept C118663420 @default.
• W2000203039 hasConcept C138850012 @default.
• W2000203039 hasConcept C145148216 @default.
• W2000203039 hasConcept C162356407 @default.
• W2000203039 hasConcept C178790620 @default.
• W2000203039 hasConcept C185592680 @default.
• W2000203039 hasConcept C198291218 @default.
• W2000203039 hasConcept C199360897 @default.
• W2000203039 hasConcept C205759337 @default.
• W2000203039 hasConcept C2779417484 @default.
• W2000203039 hasConcept C2780841973 @default.
• W2000203039 hasConcept C40325409 @default.
• W2000203039 hasConcept C41008148 @default.
• W2000203039 hasConcept C43617362 @default.
• W2000203039 hasConcept C51884965 @default.
• W2000203039 hasConcept C77281830 @default.
• W2000203039 hasConceptScore W2000203039C106186310 @default.
• W2000203039 hasConceptScore W2000203039C113196181 @default.
• W2000203039 hasConceptScore W2000203039C115139119 @default.
• W2000203039 hasConceptScore W2000203039C118663420 @default.
• W2000203039 hasConceptScore W2000203039C138850012 @default.
• W2000203039 hasConceptScore W2000203039C145148216 @default.
• W2000203039 hasConceptScore W2000203039C162356407 @default.
• W2000203039 hasConceptScore W2000203039C178790620 @default.
• W2000203039 hasConceptScore W2000203039C185592680 @default.
• W2000203039 hasConceptScore W2000203039C198291218 @default.
• W2000203039 hasConceptScore W2000203039C199360897 @default.
• W2000203039 hasConceptScore W2000203039C205759337 @default.
• W2000203039 hasConceptScore W2000203039C2779417484 @default.
• W2000203039 hasConceptScore W2000203039C2780841973 @default.
• W2000203039 hasConceptScore W2000203039C40325409 @default.
• W2000203039 hasConceptScore W2000203039C41008148 @default.
• W2000203039 hasConceptScore W2000203039C43617362 @default.
• W2000203039 hasConceptScore W2000203039C51884965 @default.

• next